Page last updated: 2024-08-21

dicyandiamido and Body Weight

dicyandiamido has been researched along with Body Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CY; Cheng, CH; Chern, JH; Chuu, JJ; Huang, CH; Huang, ZN; Li, SL; Lien, HY; Lin, CC; Wu, YY1
Kitaura, K; Mitsumori, K; Onodera, H; Shimo, T; Takahashi, M; Yasuhara, K1

Other Studies

2 other study(ies) available for dicyandiamido and Body Weight

ArticleYear
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.
    Investigational new drugs, 2011, Volume: 29, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Bromodeoxyuridine; Carcinoembryonic Antigen; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Guanidines; Humans; In Situ Nick-End Labeling; Lung; Lung Neoplasms; Mice; Mice, Nude; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Survival Analysis

2011
Lack of carcinogenicity of cyanoguanidine in F344 rats.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 1997, Volume: 35, Issue:5

    Topics: Administration, Oral; Animals; Body Weight; Carcinogenicity Tests; Eating; Female; Guanidines; Male; Neoplasms; Rats; Rats, Inbred F344; Survival Rate

1997